N. Ohno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
N. Ohno has a total of 174 co-authors. Here are the top co-authors by number of shared publications:
I Shimada
13 shared publicationsT Nishina
10 shared publicationsK Minatoya
9 shared publicationsH Okabayashi
7 shared publicationsC Pak
6 shared publicationsN Shinkura
6 shared publications
Latest Publications
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 228
Novel SiRNA Delivery Technology Promises Hope of New Approach for a Treatment of Rejection in Organ Transplantation - SiRNATargeting Co-Stimulatory Signal
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 228
Novel SiRNA Delivery Technology Promises Hope of New Approach for a Treatment of Rejection in Organ Transplantation - SiRNATargeting Co-Stimulatory Signal
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 139
A Novel Sirna Delivery System Specifically Silencing Target Gene to Induce Permanent Acceptance of Mouse Cardiac Allograft
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 139
A Novel Sirna Delivery System Specifically Silencing Target Gene to Induce Permanent Acceptance of Mouse Cardiac Allograft
- Open Access
- 27 June 2012
- Published by Wiley in Contributions to Plasma Physics
- Vol. 52 (5-6) , 484-489
Electric Field at a Plasma‐Facing Wall for a Two‐Temperature Electron Distribution
- 27 June 2012
- Published by Wiley in Contributions to Plasma Physics
- Vol. 52 (5-6) , 484-489
Open AccessElectric Field at a Plasma‐Facing Wall for a Two‐Temperature Electron Distribution
- Open Access
- 27 June 2012
- Published by Wiley in Contributions to Plasma Physics
- Vol. 52 (5-6) , 478-483
Conditions for the Release of a Metallic Dust Particle from a Plasma‐Facing Wall
- 27 June 2012
- Published by Wiley in Contributions to Plasma Physics
- Vol. 52 (5-6) , 478-483
Open AccessConditions for the Release of a Metallic Dust Particle from a Plasma‐Facing Wall
- 14 January 2010
- Vol. 27, S28-32
Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
Myeloperoxidase (MPO) -anti-neutrophil cytoplasmic autoantibodies (ANCAs) are detected at a high rate in microscopic polyangiitis and renal-limited vasculitis. MPO-ANCA titers are not always reflected in the disease activity. We studied the titer and affinity of MPO-ANCA in sera from patients in relation to vasculitis activity. Blood samples were collected from 27 newly diagnosed or relapsed patients with MPO-ANCA-associated vasculitides. The MPO-ANCA titer was determined by a direct enzyme-linked immunosorbent assay (ELISA) using homogeneously purified human MPO of leukocytes. The MPO-ANCA affinity was expressed as IC50 that was determined by a competitive inhibition method using the ELISA. The MPO-ANCA affinity of 27 sera from 27 patients could be classified into a high-affinity type (14 sera) and a low-affinity type (13 sera). The mean values for IC50 in the two types were 0.15+/-0.06 microg/ml and 0.54+/-0.15 microg/ml, and the difference was statistically significant (p<0.0000000684). Between the two groups of patients divided by the affinity, there were differences in the Birmingham Vasculitis Activity Score (BVAS): and in C-reactive protein (CRP): (p<0.00093 and p<0.00129, respectively). However, the difference in titer was not statistically significant (p<0.0265). The affinity remained steady from the disease onset to remission or relapse. The affinity of MPO-ANCA from patients with MPO-ANCA-associated vasculitides were largely distinguished into a high and a low affinity, irrespective of the level of MPO-ANCA titers, and may be helpful for assessment of vasculitis activity affecting mainly the kidney and the lung.
- 14 January 2010
- Vol. 27, S28-32
Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
Myeloperoxidase (MPO) -anti-neutrophil cytoplasmic autoantibodies (ANCAs) are detected at a high rate in microscopic polyangiitis and renal-limited vasculitis. MPO-ANCA titers are not always reflected in the disease activity. We studied the titer and affinity of MPO-ANCA in sera from patients in relation to vasculitis activity. Blood samples were collected from 27 newly diagnosed or relapsed patients with MPO-ANCA-associated vasculitides. The MPO-ANCA titer was determined by a direct enzyme-linked immunosorbent assay (ELISA) using homogeneously purified human MPO of leukocytes. The MPO-ANCA affinity was expressed as IC50 that was determined by a competitive inhibition method using the ELISA. The MPO-ANCA affinity of 27 sera from 27 patients could be classified into a high-affinity type (14 sera) and a low-affinity type (13 sera). The mean values for IC50 in the two types were 0.15+/-0.06 microg/ml and 0.54+/-0.15 microg/ml, and the difference was statistically significant (p<0.0000000684). Between the two groups of patients divided by the affinity, there were differences in the Birmingham Vasculitis Activity Score (BVAS): and in C-reactive protein (CRP): (p<0.00093 and p<0.00129, respectively). However, the difference in titer was not statistically significant (p<0.0265). The affinity remained steady from the disease onset to remission or relapse. The affinity of MPO-ANCA from patients with MPO-ANCA-associated vasculitides were largely distinguished into a high and a low affinity, irrespective of the level of MPO-ANCA titers, and may be helpful for assessment of vasculitis activity affecting mainly the kidney and the lung.
- 30 October 2006
- Published by Wiley in physica status solidi (c)
- Vol. 3 (10) , 3565-3568
Exciton luminescence of ZnO fine particles
- 30 October 2006
- Published by Wiley in physica status solidi (c)
- Vol. 3 (10) , 3565-3568
Exciton luminescence of ZnO fine particles
- 30 October 2006
- Published by Wiley in physica status solidi (c)
- Vol. 3 (10) , 3607-3610
Luminescence properties of Tl+ centers doped in KH2PO4
- 30 October 2006
- Published by Wiley in physica status solidi (c)
- Vol. 3 (10) , 3607-3610
Luminescence properties of Tl+ centers doped in KH2PO4
- 1 August 2004
- Vol. 57 (9) , 842-5
[Oral sildenafil citrate as an effective alternate in the treatment of postoperative pulmonary hypertensive crisis after congenital heart surgery].
A five-month-old girl of Down syndrome underwent a corrective surgery for complete atrioventricular septal defect. Her postoperative course was complicated with pulmonary hypertensive (PH) crises despite nitroglycerin (NTG) infusion and inhaled nitric oxide (NO). Sildenafil citrate, a phosphodiesterase 5 inhibitor, was administered through a nasogastric tube at a starting dose of 0.3 mg/kg by stepwise increment to the maximum dose of 2 mg/kg 4 hourly. Sildenafil citrate dramatically lowered pulmonary arterial pressure and the patient was weaned from NTG and NO without PH crisis. There was no side effect after sildenafil citrate administration. Oral sildenafil citrate is a safe and potent adjunct to the existing therapies for postoperative PH in infants after open heart surgery.
- 1 August 2004
- Vol. 57 (9) , 842-5
[Oral sildenafil citrate as an effective alternate in the treatment of postoperative pulmonary hypertensive crisis after congenital heart surgery].
A five-month-old girl of Down syndrome underwent a corrective surgery for complete atrioventricular septal defect. Her postoperative course was complicated with pulmonary hypertensive (PH) crises despite nitroglycerin (NTG) infusion and inhaled nitric oxide (NO). Sildenafil citrate, a phosphodiesterase 5 inhibitor, was administered through a nasogastric tube at a starting dose of 0.3 mg/kg by stepwise increment to the maximum dose of 2 mg/kg 4 hourly. Sildenafil citrate dramatically lowered pulmonary arterial pressure and the patient was weaned from NTG and NO without PH crisis. There was no side effect after sildenafil citrate administration. Oral sildenafil citrate is a safe and potent adjunct to the existing therapies for postoperative PH in infants after open heart surgery.
- 1 June 2004
- Vol. 57 (6) , 509-12
[Pulmonary metastasis of uterine leiomyosarcoma 8 years after hysterectomy; report of a case].
A 57-year-old woman, who had undergone hysterectomy for uterine leiomyosarcoma 8 years ago, was admitted to our hospital for pulmonary tumors on chest X-ray. Two tumors were recognized on each side at left and right lung field by computed tomography (CT). Two-staged tumor resection was performed by left thoracotomy and by video-assisted thoracoscopic surgery (VATS) in the right. The histologic findings showed that those tumors were metastases of uterine leiomyosarcoma. This case suggests that the long term follow-up is necessary in the case of uterine leiomyosarcoma after operation.
- 1 June 2004
- Vol. 57 (6) , 509-12
[Pulmonary metastasis of uterine leiomyosarcoma 8 years after hysterectomy; report of a case].
A 57-year-old woman, who had undergone hysterectomy for uterine leiomyosarcoma 8 years ago, was admitted to our hospital for pulmonary tumors on chest X-ray. Two tumors were recognized on each side at left and right lung field by computed tomography (CT). Two-staged tumor resection was performed by left thoracotomy and by video-assisted thoracoscopic surgery (VATS) in the right. The histologic findings showed that those tumors were metastases of uterine leiomyosarcoma. This case suggests that the long term follow-up is necessary in the case of uterine leiomyosarcoma after operation.